Last reviewed · How we verify
A Phase IV Study of Huazhi Rougan Granule
A Placebo control, Randomized, Double-blind, Multicenter Phase IV study to investigate the efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic simple fatty liver (damp-heat obstruction syndrome: Shi-Re-Zhong-Zu Zheng)
Details
| Lead sponsor | Shandong New Time Pharmaceutical Co., LTD |
|---|---|
| Phase | PHASE4 |
| Status | COMPLETED |
| Enrolment | 282 |
| Start date | Thu May 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Nov 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver
Interventions
- Huazhi Rougan Granule Placebo granule
Countries
China